John Connolly speaks on an Endpoints News panel at the 2018 BIIS PharmCube/Endpoints conference in Shanghai (File photo)

Turn­ing can­cer in­to a cur­able dis­ease: Im­munother­a­py ex­pert John Con­nol­ly picks up the reins as the new CSO of Sean Park­er’s can­cer in­sti­tute

John Con­nol­ly synced with the folks at the Park­er In­sti­tute for Can­cer Im­munother­a­py ear­ly on.

As the sci­ence chief at Sin­ga­pore-based Tes­sa Ther­a­peu­tics, he …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.